He’s Off Mealtime Insulin: Here’s His Tzield Story
Send us Fan Mail
What if a newly diagnosed person with type 1 diabetes (T1D) could dramatically reduce their insulin needs, or even stop taking mealtime insulin altogether?
In this episode of the Diabetes Nerd Podcast, we sit down with Jacob, who was diagnosed with T1D in February 2026 and enrolled in the Beta Preserve clinical trial just weeks later. The study is exploring whether two rounds of Tzield (teplizumab) can preserve insulin-producing beta cells more effectively than a single treatment.
Just months after beginning treatment, Jacob has cut his basal insulin by more than half and no…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.